# Clinical analysis of six eosinophilia cases with Löeffler endocarditis as the main clinical feature

**Authors:** 亚男 马, 苏宁 陈, 炳元 周, 小飞 杨

PMC · DOI: 10.3760/cma.j.cn121090-20250106-00008 · 2025-09-01

## TL;DR

This paper presents clinical findings from six patients with Loeffler endocarditis and eosinophilia, highlighting treatment responses and outcomes.

## Contribution

The study provides a detailed clinical analysis of six rare cases of Loeffler endocarditis with novel fusion gene findings and treatment outcomes.

## Key findings

- Two patients with FIP1L1::PDGFRA fusion responded well to imatinib therapy.
- One patient with TLS::ERG-positive AML achieved remission with chemotherapy and stem cell transplant but later relapsed.
- Three patients improved with corticosteroid treatment and remained alive at follow-up.

## Abstract

为提高对Löeffler心内膜炎的认识，回顾性分析2019年1月至2024年10月期间苏州大学附属第一医院收治的6例以Löeffler心内膜炎为主要临床特征的嗜酸性粒细胞增多症患者。6例患者中男性5例，中位年龄45.5（31～77）岁，所有患者外周血WBC、嗜酸性粒细胞计数均有增高，临床症状及影像学检查考虑为Löeffler心内膜炎，2例合并脑梗死。5例患者完善了融合基因检测，例4、例5检测到FIP1L1::PDGFRA阳性，例6诊断为TLS::ERG（+）急性髓系白血病。2例FIP1L1::PDGFRA阳性患者经伊马替尼治疗后迅速缓解；例6经糖皮质激素、羟基脲治疗后症状缓解，后接受IAG（阿糖胞苷+伊达比星+G-CSF）方案化疗后完全缓解，并于8个月后进行异基因造血干细胞移植，移植后1年因本病复发合并感染死亡。其余3例患者经糖皮质激素治疗后好转。除例6外其余患者至随访终点均存活，例4停用伊马替尼后28个月复发，再次启动治疗后缓解。

## Linked entities

- **Genes:** FIP1L1 (factor interacting with PAPOLA and CPSF1) [NCBI Gene 81608], PDGFRA (platelet derived growth factor receptor alpha) [NCBI Gene 5156], FUS (FUS RNA binding protein) [NCBI Gene 2521], ERG (ETS transcription factor ERG) [NCBI Gene 2078]
- **Chemicals:** imatinib (PubChem CID 5291), hydroxyurea (PubChem CID 3657), idarubicin (PubChem CID 42890), cytarabine (PubChem CID 6253)
- **Diseases:** Loeffler endocarditis (MONDO:0019159), acute myeloid leukemia (MONDO:0015667), brain infarction (MONDO:0005394)

## Full-text entities

- **Diseases:** acute myeloid leukemia (MESH:D015470), infection (MESH:D007239), cerebral infarction (MESH:D002544), Loeffler endocarditis (MESH:D017681), eosinophilia (MESH:D004802)
- **Chemicals:** cytarabine (MESH:D003561), idarubicin (MESH:D015255), hydroxyurea (MESH:D006918), imatinib (MESH:D000068877)
- **Species:** Homo sapiens (human, species) [taxon 9606]

---
Source: https://tomesphere.com/paper/PMC12580811